|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.South Korea |
First Approval Date03 Jul 2023 |
/ CompletedNot Applicable A 12 week Randomized, Double Blind, Placebo Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of Sunflower Seed Extract(SUN-CA) on Reducing Body Weight and Body Fat of Overweight or Obesity subjects
100 Clinical Results associated with RP Bio, lnc.
0 Patents (Medical) associated with RP Bio, lnc.
100 Deals associated with RP Bio, lnc.
100 Translational Medicine associated with RP Bio, lnc.